Secondary
NewLink Genetics
NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer
Symbol
NLNK
Last Closing Price
$10.91
Anticipated Date
TBD
Underwriters
BofA Merrill Lynch, Stifel
To view the prospectus for NewLink Genetics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277